Jim Cramer Recommends Buying Rocket Lab and Huntington Ingalls Industries, Avoids Conagra Brands
ByAinvest
Wednesday, Jul 16, 2025 12:53 am ET2min read
CAG--
Rocket Lab Corporation (NASDAQ:RKLB)
Rocket Lab, a space technology company, has seen remarkable growth, with its stock delivering a 630% return over the past year. The company's recent successful satellite launches, including the deployment of four satellites for HawkEye 360, have solidified its position in the space industry. Cantor Fitzgerald has reiterated its Overweight rating and $35.00 price target on the stock, while KeyBanc has raised its price target to $40, citing strong growth momentum [2]. Despite trading at a premium to its Fair Value, Rocket Lab's market capitalization of $16.45 billion and healthy liquidity position suggest the company is well-positioned to support its ambitious growth plans.
Huntington Ingalls Industries (NYSE:HII)
Huntington Ingalls Industries (HII) has gained a strategic edge as the exclusive designer and builder of nuclear-powered aircraft carriers in the United States. The company's strong order growth continues to translate into a robust backlog. The Zacks Consensus Estimate for HII’s 2025 earnings per share (EPS) has increased 1.2% to $14.42 per share over the past 60 days. The Zacks Consensus Estimate for HII’s total revenues for 2025 stands at $11.91 billion, indicating year-over-year growth of 3.3%. TD Cowen analyst Gautam Khanna upgraded Huntington Ingalls from Hold to Buy, recognizing the company's leadership in the US Navy shipbuilding industry [3].
Eli Lilly and Company (NYSE:LLY)
Eli Lilly and Company (LLY) is another stock that caught Cramer's attention. The pharmaceutical giant has seen remarkable strength, with a 36% revenue growth in the last twelve months. Guggenheim has raised its price target on Eli Lilly to $942.00, highlighting the company's leadership in the obesity treatment market and anticipating quarterly sales to surpass consensus expectations. Eli Lilly's recent FDA approval for a new dosing schedule of its Alzheimer’s drug, Kisunla, and the acquisition of Verve Therapeutics for up to $1.3 billion, further underscore its active role in advancing its pharmaceutical portfolio and market presence [2].
NXP Semiconductors (NASDAQ:NXPI)
NXP Semiconductors (NASDAQ:NXPI) is also on Cramer's buy list. The company has seen impressive earnings surprises and has an impressive earnings surprise history. Bernstein analyst Stacy Rasgon set a $200.00 price objective for NXP Semiconductors, while the stock currently trades at $213.08. NXP Semiconductors' recent earnings report highlighted its expansion in the AI and SDV markets, with key acquisitions and new product launches. However, the company faces challenges from broad-based revenue declines and macro headwinds, which may impact near-term growth visibility [2].
Power Solutions International (NASDAQ:PSI)
Power Solutions International (PSI) is another stock that Cramer recommends. The company is involved in the design, development, and manufacturing of power systems and components for a wide range of applications. With the growing demand for power solutions in various industries, PSI is well-positioned to benefit from long-term growth trends.
Conclusion
Jim Cramer's recommendations provide investors with a clear view of the current market sentiment and potential investment opportunities. Rocket Lab, Huntington Ingalls, Eli Lilly, NXP Semiconductors, and Power Solutions International have shown strong performance and growth potential, making them attractive choices for investors. However, it is essential to conduct thorough research and consider individual risk tolerance and investment goals before making any investment decisions.
References
[1] https://finance.yahoo.com/news/rocket-lab-rklb-jumps-10-181904057.html
[2] https://www.ainvest.com/news/cramer-stock-picks-buy-rocket-lab-nxp-semiconductors-eli-lilly-2507/
[3] https://www.nasdaq.com/articles/heres-why-you-should-add-huntington-ingalls-your-portfolio
CEPT--
HII--
LLY--
NXPI--
Jim Cramer recommends buying Rocket Lab Corporation, Huntington Ingalls Industries, Eli Lilly and Company, NXP Semiconductors, and Power Solutions International. He advises against Conagra Brands, calling it a "very tough situation". TD Cowen analyst Gautam Khanna upgraded Huntington Ingalls from Hold to Buy, and Guggenheim analyst Seamus Fernandez maintained Eli Lilly with a Buy and raised the price target from $936 to $942.
Jim Cramer, the well-known financial expert and host of CNBC's "Mad Money," recently shared his insights on several stocks, offering valuable recommendations for investors. Among his picks are Rocket Lab Corporation (NASDAQ:RKLB), Huntington Ingalls Industries (NYSE:HII), Eli Lilly and Company (NYSE:LLY), NXP Semiconductors (NASDAQ:NXPI), and Power Solutions International (NASDAQ:PSI). Cramer also advised against investing in Conagra Brands (NYSE:CAG) due to its challenging situation.Rocket Lab Corporation (NASDAQ:RKLB)
Rocket Lab, a space technology company, has seen remarkable growth, with its stock delivering a 630% return over the past year. The company's recent successful satellite launches, including the deployment of four satellites for HawkEye 360, have solidified its position in the space industry. Cantor Fitzgerald has reiterated its Overweight rating and $35.00 price target on the stock, while KeyBanc has raised its price target to $40, citing strong growth momentum [2]. Despite trading at a premium to its Fair Value, Rocket Lab's market capitalization of $16.45 billion and healthy liquidity position suggest the company is well-positioned to support its ambitious growth plans.
Huntington Ingalls Industries (NYSE:HII)
Huntington Ingalls Industries (HII) has gained a strategic edge as the exclusive designer and builder of nuclear-powered aircraft carriers in the United States. The company's strong order growth continues to translate into a robust backlog. The Zacks Consensus Estimate for HII’s 2025 earnings per share (EPS) has increased 1.2% to $14.42 per share over the past 60 days. The Zacks Consensus Estimate for HII’s total revenues for 2025 stands at $11.91 billion, indicating year-over-year growth of 3.3%. TD Cowen analyst Gautam Khanna upgraded Huntington Ingalls from Hold to Buy, recognizing the company's leadership in the US Navy shipbuilding industry [3].
Eli Lilly and Company (NYSE:LLY)
Eli Lilly and Company (LLY) is another stock that caught Cramer's attention. The pharmaceutical giant has seen remarkable strength, with a 36% revenue growth in the last twelve months. Guggenheim has raised its price target on Eli Lilly to $942.00, highlighting the company's leadership in the obesity treatment market and anticipating quarterly sales to surpass consensus expectations. Eli Lilly's recent FDA approval for a new dosing schedule of its Alzheimer’s drug, Kisunla, and the acquisition of Verve Therapeutics for up to $1.3 billion, further underscore its active role in advancing its pharmaceutical portfolio and market presence [2].
NXP Semiconductors (NASDAQ:NXPI)
NXP Semiconductors (NASDAQ:NXPI) is also on Cramer's buy list. The company has seen impressive earnings surprises and has an impressive earnings surprise history. Bernstein analyst Stacy Rasgon set a $200.00 price objective for NXP Semiconductors, while the stock currently trades at $213.08. NXP Semiconductors' recent earnings report highlighted its expansion in the AI and SDV markets, with key acquisitions and new product launches. However, the company faces challenges from broad-based revenue declines and macro headwinds, which may impact near-term growth visibility [2].
Power Solutions International (NASDAQ:PSI)
Power Solutions International (PSI) is another stock that Cramer recommends. The company is involved in the design, development, and manufacturing of power systems and components for a wide range of applications. With the growing demand for power solutions in various industries, PSI is well-positioned to benefit from long-term growth trends.
Conclusion
Jim Cramer's recommendations provide investors with a clear view of the current market sentiment and potential investment opportunities. Rocket Lab, Huntington Ingalls, Eli Lilly, NXP Semiconductors, and Power Solutions International have shown strong performance and growth potential, making them attractive choices for investors. However, it is essential to conduct thorough research and consider individual risk tolerance and investment goals before making any investment decisions.
References
[1] https://finance.yahoo.com/news/rocket-lab-rklb-jumps-10-181904057.html
[2] https://www.ainvest.com/news/cramer-stock-picks-buy-rocket-lab-nxp-semiconductors-eli-lilly-2507/
[3] https://www.nasdaq.com/articles/heres-why-you-should-add-huntington-ingalls-your-portfolio

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet